XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Common stock, balance at beginning of period (in shares) at Dec. 31, 2019   208,116,104      
Balance at beginning of period at Dec. 31, 2019 $ 121,142 $ 208 $ 459,573 $ (338,611) $ (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 13,040     13,040  
Capital contributions 1,083   1,083    
Stock-based compensation 1,379   1,379    
Compensatory units repurchased (732)   (732)    
Other comprehensive income (loss) 98       98
Common stock, balance at end of period (in shares) at Mar. 31, 2020   208,116,104      
Balance at end of period at Mar. 31, 2020 136,010 $ 208 461,303 (325,571) 70
Common stock, balance at beginning of period (in shares) at Dec. 31, 2019   208,116,104      
Balance at beginning of period at Dec. 31, 2019 121,142 $ 208 459,573 (338,611) (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 47,919        
Reclassification of liability awards to equity upon modification 0        
Other comprehensive income (loss) 65        
Common stock, balance at end of period (in shares) at Jun. 30, 2020   208,116,104      
Balance at end of period at Jun. 30, 2020 170,057 $ 208 460,504 (290,692) 37
Common stock, balance at beginning of period (in shares) at Mar. 31, 2020   208,116,104      
Balance at beginning of period at Mar. 31, 2020 136,010 $ 208 461,303 (325,571) 70
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 34,879     34,879  
Capital contributions 4   4    
Stock-based compensation 827   827    
Compensatory units repurchased (1,630)   (1,630)    
Other comprehensive income (loss) (33)       (33)
Common stock, balance at end of period (in shares) at Jun. 30, 2020   208,116,104      
Balance at end of period at Jun. 30, 2020 170,057 $ 208 460,504 (290,692) 37
Common stock, balance at beginning of period (in shares) at Dec. 31, 2020   208,116,104      
Balance at beginning of period at Dec. 31, 2020 228,925 $ 208 412,741 (184,033) 9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 49,418     49,418  
Capital contributions 200   200    
Initial public offering, net of offering costs (in shares)   13,250,000      
Initial public offering, net of offering costs 242,668 $ 13 242,655    
Repurchase upon corporate reorganization (in shares)   (524)      
Repurchase upon Corporate Reorganization (10)   (10)    
Reclassification of liability awards to equity upon modification 10,784   10,784    
Stock-based compensation 6,635   6,635    
Compensatory units repurchased (160)   (160)    
Other comprehensive income (loss) (13)       (13)
Common stock, balance at end of period (in shares) at Mar. 31, 2021   221,365,580      
Balance at end of period at Mar. 31, 2021 538,447 $ 221 672,845 (134,615) (4)
Common stock, balance at beginning of period (in shares) at Dec. 31, 2020   208,116,104      
Balance at beginning of period at Dec. 31, 2020 228,925 $ 208 412,741 (184,033) 9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 98,544        
Reclassification of liability awards to equity upon modification 10,784        
Other comprehensive income (loss) (9)        
Common stock, balance at end of period (in shares) at Jun. 30, 2021   222,253,059      
Balance at end of period at Jun. 30, 2021 613,612 $ 222 698,879 (85,489) 0
Common stock, balance at beginning of period (in shares) at Mar. 31, 2021   221,365,580      
Balance at beginning of period at Mar. 31, 2021 538,447 $ 221 672,845 (134,615) (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 49,126     49,126  
Initial public offering, net of offering costs (in shares)   968,815      
Initial public offering, net of offering costs 18,020 $ 1 18,019    
Stock-based compensation 8,015   8,015    
Other comprehensive income (loss) 4       4
Issuance of common stock upon vesting of restricted stock units (in shares)   64,566      
Issuance of common stock upon vesting of restricted stock units 0        
Forfeiture of unvested common stock (in shares)   (145,902)      
Forfeiture of unvested common stock 0        
Common stock, balance at end of period (in shares) at Jun. 30, 2021   222,253,059      
Balance at end of period at Jun. 30, 2021 $ 613,612 $ 222 $ 698,879 $ (85,489) $ 0